Fresenius SE & Co. KGaA (FRE.DE)
EUR 34.19
(0.41%)
EUR 34.19
(0.41%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 2.73 Billion EUR | -57.92% |
| 2022 | 3.09 Billion EUR | -6.73% |
| 2021 | 6.84 Billion EUR | -2.97% |
| 2020 | 7.18 Billion EUR | -0.75% |
| 2019 | 7.2 Billion EUR | 34.9% |
| 2018 | 6.84 Billion EUR | 6.89% |
| 2017 | 6.22 Billion EUR | 11.32% |
| 2016 | 5.61 Billion EUR | 4.39% |
| 2015 | 4.95 Billion EUR | 25.39% |
| 2014 | 4.01 Billion EUR | 8.77% |
| 2013 | 3.83 Billion EUR | 2.47% |
| 2012 | 3.88 Billion EUR | -3.51% |
| 2011 | 3.19 Billion EUR | 5.69% |
| 2010 | 3.01 Billion EUR | 15.88% |
| 2009 | 2.6 Billion EUR | 33.76% |
| 2008 | 2.04 Billion EUR | 134.54% |
| 2007 | 2.05 Billion EUR | 13.99% |
| 2006 | 729 Million EUR | 34.5% |
| 2005 | 1.3 Billion EUR | 12.22% |
| 2004 | 483 Million EUR | -27.15% |
| 2003 | 1.08 Billion EUR | -2.07% |
| 2002 | 1.15 Billion EUR | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | 587 Million EUR | -30.94% |
| 2024 Q1 | 850 Million EUR | 21.78% |
| 2023 Q4 | 804 Million EUR | 132.37% |
| 2023 FY | - EUR | -57.92% |
| 2023 Q1 | 1.49 Billion EUR | -12.29% |
| 2023 Q2 | 1.24 Billion EUR | -16.36% |
| 2023 Q3 | 346 Million EUR | -72.25% |
| 2022 Q3 | 1.65 Billion EUR | 8.51% |
| 2022 Q4 | 1.7 Billion EUR | 2.53% |
| 2022 FY | - EUR | -6.73% |
| 2022 Q1 | 1.59 Billion EUR | -19.93% |
| 2022 Q2 | 1.52 Billion EUR | -4.2% |
| 2021 Q4 | 1.99 Billion EUR | 56.48% |
| 2021 Q2 | 1.3 Billion EUR | 3.9% |
| 2021 Q1 | 1.25 Billion EUR | -16.05% |
| 2021 Q3 | 1.27 Billion EUR | -2.38% |
| 2021 FY | - EUR | -2.97% |
| 2020 Q4 | 1.49 Billion EUR | 19.22% |
| 2020 Q1 | 1.48 Billion EUR | -16.63% |
| 2020 Q2 | 1.44 Billion EUR | -2.9% |
| 2020 Q3 | 1.25 Billion EUR | -12.98% |
| 2020 FY | - EUR | -0.75% |
| 2019 FY | - EUR | 34.9% |
| 2019 Q1 | 1.42 Billion EUR | -9.06% |
| 2019 Q4 | 1.78 Billion EUR | 23.1% |
| 2019 Q3 | 1.44 Billion EUR | -0.14% |
| 2019 Q2 | 1.44 Billion EUR | 1.61% |
| 2018 Q3 | 1.11 Billion EUR | -27.93% |
| 2018 Q4 | 1.56 Billion EUR | 40.92% |
| 2018 FY | - EUR | 6.89% |
| 2018 Q1 | 1.12 Billion EUR | -13.57% |
| 2018 Q2 | 1.54 Billion EUR | 36.91% |
| 2017 Q1 | 1.26 Billion EUR | -2.99% |
| 2017 Q4 | 1.3 Billion EUR | 11.07% |
| 2017 Q3 | 1.17 Billion EUR | -6.83% |
| 2017 FY | - EUR | 11.32% |
| 2017 Q2 | 1.26 Billion EUR | -0.47% |
| 2016 Q4 | 1.3 Billion EUR | 20.06% |
| 2016 Q2 | 1.08 Billion EUR | 5.97% |
| 2016 Q1 | 1.02 Billion EUR | -22.71% |
| 2016 FY | - EUR | 4.39% |
| 2016 Q3 | 1.08 Billion EUR | 0.46% |
| 2015 Q1 | 950 Million EUR | -3.55% |
| 2015 FY | - EUR | 25.39% |
| 2015 Q4 | 1.32 Billion EUR | 26.53% |
| 2015 Q3 | 1.04 Billion EUR | 5.35% |
| 2015 Q2 | 991 Million EUR | 4.32% |
| 2014 FY | - EUR | 8.77% |
| 2014 Q2 | 855 Million EUR | 14.92% |
| 2014 Q3 | 850 Million EUR | -0.58% |
| 2014 Q4 | 985 Million EUR | 15.88% |
| 2014 Q1 | 744 Million EUR | -14.58% |
| 2013 Q2 | 766 Million EUR | 3.93% |
| 2013 Q3 | 783 Million EUR | 2.22% |
| 2013 Q4 | 871 Million EUR | 11.24% |
| 2013 FY | - EUR | 2.47% |
| 2013 Q1 | 737 Million EUR | 22.43% |
| 2012 Q4 | 602 Million EUR | -1.95% |
| 2012 FY | - EUR | -3.51% |
| 2012 Q2 | 777 Million EUR | -1.4% |
| 2012 Q1 | 788 Million EUR | 3.28% |
| 2012 Q3 | 614 Million EUR | -20.98% |
| 2011 Q3 | 744 Million EUR | 33.09% |
| 2011 Q4 | 763 Million EUR | 2.55% |
| 2011 FY | - EUR | 5.69% |
| 2011 Q2 | 559 Million EUR | -17.19% |
| 2011 Q1 | 675 Million EUR | -22.86% |
| 2010 FY | - EUR | 15.88% |
| 2010 Q4 | 875 Million EUR | 7.49% |
| 2010 Q2 | 731 Million EUR | 22.24% |
| 2010 Q1 | 598 Million EUR | -17.63% |
| 2010 Q3 | 814 Million EUR | 11.35% |
| 2009 Q3 | 578 Million EUR | -5.71% |
| 2009 Q2 | 613 Million EUR | -11.16% |
| 2009 Q1 | 690 Million EUR | 0.0% |
| 2009 FY | - EUR | 33.76% |
| 2009 Q4 | 726 Million EUR | 25.61% |
| 2008 FY | - EUR | 134.54% |
| 2007 FY | - EUR | 13.99% |
| 2006 FY | - EUR | 34.5% |
| 2005 FY | - EUR | 12.22% |
| 2004 FY | - EUR | -27.15% |
| 2003 FY | - EUR | -2.07% |
| 2002 FY | - EUR | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Fresenius Medical Care AG & Co. KGaA | 2.93 Billion EUR | 6.778% |
| LIMES Schlosskliniken AG | 854.98 Thousand EUR | -319790.15% |
| M1 Kliniken AG | 21.79 Million EUR | -12450.079% |
| Maternus-Kliniken Aktiengesellschaft | 4.71 Million EUR | -57906.363% |
| MEDICLIN Aktiengesellschaft | 101.26 Million EUR | -2600.851% |
| RHÖN-KLINIKUM Aktiengesellschaft | 116.58 Million EUR | -2245.988% |
| VITA 34 AG | 5.8 Million EUR | -47006.442% |